Double membrane transducer protector
13 claims: 8 independent, 5 dependent
- 1A transducer protector device (10), comprising:a first tubular connector (20) being configured for connection to a first tube;a second tubular connector (30) being configured for connection to a second tube;and a body (40) positioned between said first (20) and second (30) tubular connectors, wherein a first filter member (50) is positioned between said body (40) and said first tubular connector (20), and wherein a second filter member (60) is positioned between said body (40) and said second tubular connector (30), wherein at least a portion of said body (40) is made of a transparent material, and wherein said body (40) further comprises a biological or chemical indicator (70).
- 11The device of any of claims 1 to 10, wherein said first tubular connector (20) has a first and a second end, said first end comprising a female connector luer (24), said second end comprising a flange (26);said second tubular connector (30) has a first and a second end, said first end comprising a male connector luer (34), said second end comprising a flange (36);said body (40) has a first and a second end, said first and second ends comprising first and second flanges (46), respectively;said first filter member (50) is captured between said first tubular connector flange (26) and said first body flange (46);and said second filter member (60) is captured between said second tubular connector flange (36) and said second body flange (46).
Independent claims8
23 paragraphs in 4 sections, as filed
BACKGROUND OF THE INVENTION
0001Hemodialysis, the most frequently used method for treating advanced and chronic kidney failure consists of a continuous process of removing blood from a patient, cleansing the blood with a special filter mounted on a dialysis machine, and returning the cleansed blood back to the patient. During the hemodialysis procedure, a trained health-care professional will continuously monitor the arterial (pre- and/or post-pump) and venous pressure in the extracorporeal circuit. This is typically done through a tube positioned between the extracorporeal circuit and the dialysis machine. A transducer protector is an in-line sterile barrier and is recommended to be placed between the monitoring line and the dialysis machine. The main purpose of the transducer protector, if correctly used, is to prevent cross-contamination between patients. With dialysis machines, blood must be contained to the extracorporeal circuit, while the safe operation of the dialysis session depends on the ability to accurately measure the pressure in the extracorporeal circuit. The hydrophobic nature of the membrane in the transducer protector prevents fluid (e.g., blood) from passing through the membrane while allowing air to flow freely across the membrane, facilitating accurate pressure measurements. At the end of the dialysis session, the transducer protector and the extracorporeal circuit (blood tubing sets) are discarded and replaced by a new sterile set for the next dialysis sessions.
0002The transducer protector generally consists of two components sealed around a filtering hydrophobic membrane, which acts as a sterile barrier. The two components can be any combination of a male-male, female-female and male-female connectors that attach to medical equipment. The transducer protector is essential in shielding the dialysis equipment and patients from risks of contamination by infected blood. Typical transducer protector devices are described in <patcit id="pcit0001" dnum="US5500003A"><text>U.S. Pat. Nos. 5,500,003</text></patcit> and <patcit id="pcit0002" dnum="US5603792A"><text>5,603,792 to Guala et al.</text></patcit>; <patcit id="pcit0003" dnum="US6086762A"><text>U.S. Pat. No. 6,086,762 to Guala</text></patcit>; <patcit id="pcit0004" dnum="US6168653B"><text>U.S. Pat. No. 6,168,653 to Myers</text></patcit> and <patcit id="pcit0005" dnum="US6536278B"><text>U.S. Pat. No. 6,536,278 to Scagliarini</text></patcit>. These references all disclose transducer protectors of various configurations, but with the common features described above of a single filtering membrane between two tubular connectors.
0003Due to the high risk of blood contamination and incidents involving wetted/breached membranes in transducer protectors, which can occur due to fluctuation of fluid levels in the arterial and/or venous drip chamber, as well as due to changes of pressures in the extracorporeal circuit, it has become necessary to provide further protection between the pressure-sensing port of the hemodialysis machine and the extracorporeal circuit. Proposals for further protection include placing one or more redundant transducer protectors in the system and/or utilizing transducer protectors with luer extensions so that visual inspection of failure is facilitated. However, drawbacks to these solutions include, but are not limited to, the fact that they are bulky to use, they offer increased risk of non-sterile procedures, and they generally employ poor connections between the different transducer protectors.
0004Therefore, it would be desirable to provide a transducer protector that would provide increased protection, that would provide to a clinician or physician monitoring a dialysis system means of detection, would reduce necessary handling and connecting, would maintain connection sterility, would increase more precise pressure monitoring, and would reduce inventory control, thus providing cost savings to the users.
0005It is to be noted that <patcit id="pcit0006" dnum="US5914033A"><text>US 5,914,033 to Carlsson</text></patcit> describes a removable insert for positioning within a medical treatment apparatus in order to connect a pressure transducer to an external apparatus with an associated pressure that is to be monitored by the pressure transducer. A tube contains a first blood filter and is connected to a first luer-coupling, while a second luer-coupling contains a second blood filter and is connected to the first luer-coupling.
0006<patcit id="pcit0007" dnum="WO2004082732A2"><text>WO 2004/082732 A2</text></patcit> describes a device for protecting a medical apparatus from contamination by infectious agents, comprising a contaminant body having an inlet to be set in fluid communication with an extracorporeal circuit of blood. The device has an outlet to be connected to a fluid line operatively connected to a pressure gauge of a medical apparatus. Two hydrophobic membranes are predisposed in the containment body between the inlet and the outlet.
0007<patcit id="pcit0008" dnum="US4493693A"><text>US 4,493,693</text></patcit> describes a monitoring system for monitoring trans-membrane pressure in a plasmapheresis or hemodialysis apparatus. Isolator devices are described to be effective in preventing contamination from leaving and entering the respective systems and it is suggested that in-line microporous hydrophobic filters could be used instead.
0008<patcit id="pcit0009" dnum="DE19816871A1"><text>DE 198 16 871 A1</text></patcit> describes a filtration unit having two hydrophobic membranes which work as fluid barriers and protection for a moisture-sensitive apparatus while removing contamination.
BRIEF SUMMARY OF THE INVENTION
0009Accordingly, the present invention provides a transducer protector device according to claim 1. The biological or chemical indicator can be in the form of a biological or chemical material and may include the feature of changing color upon contact with a bodily fluid.
0010The body and first and second tubular connectors can include axially aligned lumen and can be connected together via ultrasonic welding, heat sealing, RF welding and even self-adhesive patches. In one embodiment of the invention, the first and second tubular connectors have a luer connector end and a flanged end, the flanged end for the first and second tubular connectors each being configured for mating with flanged ends on the body. The first tubular connector may have a male luer connector and the second tubular connector may have a female luer connector. However, such connector types can be reversed or both connectors can be either a male connector or a female connector. Further, the connectors can be fashioned as neither male or female, but instead in the configuration of a slip end. Moreover, the first and second filter members can be secured in place between the mating portion of the flanged sections of the body and the first and second tubular connectors.
0011These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.
BRIEF DESCRIPTION OF THE DRAWINGS
0012<dl id="dl0001"><dt>FIG. 1</dt><dd>is a transducer protector according to the present invention (biological or chemical indicator not schown), shown in cross-section.</dd><dt>FIG. 2</dt><dd>is an enlarged view of section "2" indicated in <figref idref="f0001">FIG. 1</figref>.</dd><dt>FIG. 3</dt><dd>is a view, in isolation, of the body of the transducer protector of <figref idref="f0001">FIG. 1</figref>, illustrating an alternate embodiment of the present invention.</dd><dt>FIG. 4</dt><dd>is a perspective view of the transducer protector of <figref idref="f0001">FIG. 1</figref> attached to a dialysis machine, illustrating the use of a sensor clip therewith.</dd></dl>
DETAILED DESCRIPTION OF THE INVENTION
0013The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
0014The present invention is directed to a transducer protector containing more than one filter membrane so that detection of a breached or wetted membrane can lead to prevention of system contamination (in contradistinction to the prior art devices in which detection of a breached or wetted membrane could likely lead to extensive system contamination). To that end, the examples herein are directed to a transducer protector having two filter membranes that are spaced apart by a body having a length. It should be appreciated, however, that although the examples and embodiments described herein are in connection with a transducer protector having two filter membranes, it is equally within the scope of the present invention for the transducer protector to contain a number of filter membranes, i.e., three, four, five, etc., the thrust of the invention being that multiple barriers within a single device are provided. At the same time, the present invention is directed to a transducer protector that contains within it a biological and/or chemical indicator to alert a clinician or physician that a potential contaminant has bypassed the initial barrier (membrane).
0015By providing a single transducer protector that includes more than one filter membrane along with a detection system in form of a biological or chemical indicator, various objectives are achieved. Notably, utilization of such a transducer protector in a system would be advantageous over systems having two or more independent transducer protectors in that there is a reduction in the necessity of handling and connecting and hence a reduction for a possible contamination risk caused by a non-sterile technique when connecting two or more transducer protectors, and the inventory control is reduced by at least half. Moreover, incorporating multiple filters into one device ostensibly provides cost savings to the users. Additionally, the use of one, as opposed to multiple, separate transducer protectors provides increased sterility and should enable more precise pressure monitoring.
0016Referring now to <figref idref="f0001">FIG. 1</figref>, a transducer protector 10 of the present invention is illustrated, having a first tubular connector 20, a second tubular connector 30 and a body 40.
0017The first tubular connector 20 has a lumen 22 and a female luer connector 24. The first tubular connector 20 is attached to the body 40 along a flanged section 26, while the second tubular connector 30 is attached to the body 40 along a flanged section 36. The body 40 has flanged areas 46 that are configured to mate with flanged sections 26, 36. More particularly, as seen in <figref idref="f0002">FIG. 2</figref> in connection with the first tubular connector 20 and the body 40, flanged section 26 contains receiving portions 25, 27 and a projection 29, which correspondingly mate with projections 45, 47 and receiving portion 49. In this embodiment, ultrasonic welding connections between the flanged sections 26 and 46 occur circumferentially along the aforementioned mating portions and projections to seal the body 40 to the first tubular connector 20. The second tubular connector 30 is likewise attached to the body 40. Of course, it should be appreciated that the body 40 could be connected to the tubular connectors 20, 30 by many other methods other than ultrasonic welding, including, but not limited to, use of adhesives, heat sealing, RF welding, and even self-adhesive patches.
0018As shown in <figref idref="f0001">FIGS. 1</figref> and <figref idref="f0002">2</figref>, between both tubular connectors 20, 30 and the body 40, there is positioned filter membranes 50, 60 respectively. Filter membranes 50, 60 can be made of PTFE (polytetrafluoroethylene), although certainly other materials such as polypropylene, PES, PVDF (polyvinylidene difluoride), acrylic copolymer and other combinations of polymeric materials, would also be suitable for forming a contaminant barrier. The filter membranes 50, 60 are attached in place at the periphery thereof, being sandwiched between the body 40 and the tubular connectors 20, 30, respectively. With reference to tubular connector 20 and body 40, the sandwiching of the filter membrane 50 occurs between receiving portion 25 and projection 45, as shown in <figref idref="f0002">FIG. 2</figref>. In order to ensure that filter membrane 50 is secured in place, a length 52 must be between the respective body portion and tubular connector portion (in this case, receiving portion 25 and projection 45). Of course, depending on the materials involved and method of attachment, this required length can vary. In this embodiment, length 52 is between the range of approximately 2 mm to 10 mm. It should be appreciated that filter membrane 60 is similarly secured in place along a necessary length between flanges 36 and 46.
0019Referring again to <figref idref="f0001">FIG. 1</figref>, the first tubular portion 20 is shown with a female luer connector 24, which in this embodiment is configured for connection with a male luer connector (not shown) on the sterile side of the transducer protector 10, or the side connected to the dialysis machine. The second tubular portion 30, on the other hand, is shown with a male luer connector, which in this embodiment is configured for connection with a female luer connector (not shown) on the non-sterile side of the transducer protector 10, or the side connected to a gauge or other pressure sensitive device. Of course, the connectors on either the sterile or non-sterile side can be of many different types, depending on the connection requirements of the system. First tubular connector 20 has a lumen 22, which, when connected, is in fluid communication with tubing (not shown) connected to a dialysis machine, whereas second tubular connector 30 has a lumen 32, which, when connected, is in fluid communication with tubing (not shown) connected to a pressure sensitive device.
0020Body 40 has a lumen 42, which in this embodiment is axially aligned with the lumens 22, 32 of the tubular connectors 20, 30 respectively. In the preferred embodiment, the body 40 is made of a transparent material so that the lumen 42 can be seen by the clinician or physician that is monitoring the transducer protector 10. Thus, if blood comes through lumen 22 and into contact with the filter membrane 50 and contaminant enters lumen 42, the clinician or physician will be able to take immediate action to prevent further progress of the blood or contaminant toward and in contact with the filter membrane 60. To further this goal of providing time to prevent contamination, the filter membranes 50 and 60 should be separated by a distance, which distance in this embodiment would be length 44. In the described embodiment, the optimal distance between the filter membranes 50,60 to provide adequate warning, while maintaining an acceptable size has been found to be in the range of approximately 15 mm to 30 mm. However, depending on the materials of the parts and/or the particular application, certainly this distance could be shortened or extended and any distance would be within the scope of the present invention.
0021Referring to <figref idref="f0002">FIG. 3</figref>, furthering the goal of providing a means of detection for a clinician or physician monitoring a dialysis system, an embodiment is shown in which the body lumen 42 has a coating 70 thereon to assist in providing a signal to the clinician or physician regarding fluid or airborne pathogens that have progressed beyond the filter membrane 50. The coating could, for example, immediately change color upon contact with a contaminant, such as blood, to provide the signal to the clinician. Of course, many different materials would be possible for the coating 70, as would be apparent to one of skill in the art, which could provide a number of different indicators other than a color change. While the coating is shown on a certain section of a wall of the lumen 42, certainly as necessary, the entire circumference of the wall could be coated. Likewise, although a majority of the length of the lumen 42 is shown with a coating 70 thereon, it should be appreciated that smaller or longer segments of the lumen 42 could be coated, depending on the particular materials used and/or the application involved. Moreover, while a coating 70 is shown, various different chemical or biological indicators are also possible in place of or in addition to the coating 70, as would be apparent to one of skill in the art.
0022<figref idref="f0003">FIG. 4</figref> illustrates a further means of monitoring the transducer protector 10. In this embodiment, the transducer protector 10 is attached to a dialysis machine 100 on one side and to a monitoring line 110 of a blood tubing set on the opposite side. A sensor clip 60 is then clipped to the body 40. The sensor clip 60 utilizes optical or other means to detect whether a contaminant is present in the body lumen 42 after having breached the filter membrane separating the monitoring line 110 from the body 40. Once a contaminant is detected, a signal is immediately transmitted to a warning device, which can be incorporated into a dialysis machine or can be a stand alone device, which alerts the clinician that a breach has occurred. Due to the dual membrane properties of the transducer protector 10, the clinician is able to prevent the contaminant from reaching the dialysis machine 100. It should be understood that the sensor clip 60 could be used in combination with any of the aforementioned biological or chemical indicators.
0023The present invention has been described above in terms of certain preferred embodiments so that an understanding of the present invention can be conveyed. However, there are many alternative arrangements not specifically described herein but with which the present invention is applicable. Although specific features have been provided, the device of the present invention would equally be embodied by other configurations not specifically recited herein. The scope of the present invention should therefore not be limited by the embodiments illustrated, but rather it should be understood that the present invention has wide applicability with respect to transducer protectors generally. All modifications, variations, or equivalent elements and implementations that are within the scope of the appended claims should therefore be considered within the scope of the invention.
Contents4
3 sheets
Sheet 1 Sheet 2 Sheet 3
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2009030056A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| WO2004082732A | Cites | World Intellectual Property Organization (WIPO) | – |
| DE19816871A1 | Cites | Germany | – |
| GB2168263A | Cites | United Kingdom | – |
| US4493693A | Cites | United States of America | – |
17 members in 8 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 745390 | United States of America | – | |
| 74539003 | United States of America | A | |
| 74539003 | United States of America | A | |
| 745390 | – | – | – |
| US20030745390 | – | – | – |
Members17
| Document | Office | Kind | |
|---|---|---|---|
| CA2490552A1 | Canada | A1 | |
| US2005132826A1 | United States of America | A1 | |
| EP1547630A1 | European Patent Office (EPO) | A1 | |
| AU2004242431A1 | Australia | A1 | |
| US7069788B2 | United States of America | B2 | |
| US2007014689A1 | United States of America | A1 | |
| WO2008002370A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2008002370A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1547630B1This record | European Patent Office (EPO) | B1 | |
| AT392909T | Austria | T | |
| ATE392909T1 | Austria | T1 | |
| DE602004013263D1 | Germany | D1 | |
| ES2301926T3 | Spain | T3 | |
| AU2004242431B2 | Australia | B2 | |
| US7516665B2 | United States of America | B2 | |
| DE602004013263T2 | Germany | T2 | |
| CA2490552C | Canada | C |
61 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fr: translation filedET | ET | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| European patents granted designating irelandGrantedLANGUAGE OF EP DOCUMENT: FRENCHFG4D | FG4D | IE | |
| Corresponds to:REF | REF | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Designation fees paidAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1547630
- Publication, DOCDB
- 1547630
- Publication, EPODOC
- EP1547630
- Application
- 4030481
- Application, DOCDB
- 04030481
- Application, EPODOC
- EP20040030481
Titles3
- German
- Sensorschutzvorrichtung mit Doppelmembran
- English
- Double membrane transducer protector
- French
- Protection à double membrane pour un transducteur
Classification
- CPC, 7
- A61M1/3639
- A61M2205/15
- A61M2205/16
- A61M2205/7527
- A61M2205/7536
- G01L19/0636
- A61M1/3641
- IPC, 2
- A61M1 36
- G01L19 06
Designated states1
- Contracting states, 1
- Türkiye
